312 related articles for article (PubMed ID: 26875134)
21. 5-Fluorouracil, capecitabine and vasospasm: a scoping review of pathogenesis, management options and future research considerations.
Teperikidis E; Boulmpou A; Charalampidis P; Tsavousoglou C; Giannakoulas G; Papadopoulos CE; Vassilikos V
Acta Cardiol; 2022 Feb; 77(1):1-13. PubMed ID: 33683181
[TBL] [Abstract][Full Text] [Related]
22. Continuation of fluoropyrimidine treatment with S-1 after cardiotoxicity on capecitabine- or 5-fluorouracil-based therapy in patients with solid tumours: a multicentre retrospective observational cohort study.
Osterlund P; Kinos S; Pfeiffer P; Salminen T; Kwakman JJM; Frödin JE; Shah CH; Sorbye H; Ristamäki R; Halonen P; Soveri LM; Heervä E; Ålgars A; Bärlund M; Hagman H; McDermott R; O'Reilly M; Röckert R; Liposits G; Kallio R; Flygare P; Teske AJ; van Werkhoven E; Punt CJA; Glimelius B
ESMO Open; 2022 Jun; 7(3):100427. PubMed ID: 35798468
[TBL] [Abstract][Full Text] [Related]
23. Emergency use of uridine triacetate for the prevention and treatment of life-threatening 5-fluorouracil and capecitabine toxicity.
Ma WW; Saif MW; El-Rayes BF; Fakih MG; Cartwright TH; Posey JA; King TR; von Borstel RW; Bamat MK
Cancer; 2017 Jan; 123(2):345-356. PubMed ID: 27622829
[TBL] [Abstract][Full Text] [Related]
24. Severe sequence-specific toxicity when capecitabine is given after Fluorouracil and leucovorin.
Hennig IM; Naik JD; Brown S; Szubert A; Anthoney DA; Jackson DP; Melcher AM; Crawford SM; Bradley C; Brown JM; Seymour MT
J Clin Oncol; 2008 Jul; 26(20):3411-7. PubMed ID: 18612156
[TBL] [Abstract][Full Text] [Related]
25. Patients with locally advanced and metastatic colorectal cancer treated with capecitabine versus 5-fluorouracil as monotherapy or combination therapy with oxaliplatin: a cost comparison.
Chu E; Schulman KL; McKenna EF; Cartwright T
Clin Colorectal Cancer; 2010 Oct; 9(4):229-37. PubMed ID: 20920995
[TBL] [Abstract][Full Text] [Related]
26. Prinzmetal angina (Coronary vasospasm) associated with 5-fluorouracil chemotherapy.
Ben-Yakov M; Mattu A; Brady WJ; Dubbs SB
Am J Emerg Med; 2017 Jul; 35(7):1038.e3-1038.e5. PubMed ID: 28283339
[TBL] [Abstract][Full Text] [Related]
27. [Cardiotoxicity of 5-fluorouracil. Spasm or direct myocardial toxicity?].
Thyss A; Falewee MN; Leborgne L; Viens P; Schneider M; Demard F
Bull Cancer; 1987; 74(4):381-5. PubMed ID: 3663962
[TBL] [Abstract][Full Text] [Related]
28. 5-Fluorouracil-induced coronary vasospasm.
Bathina JD; Yusuf SW
J Cardiovasc Med (Hagerstown); 2010 Apr; 11(4):281-4. PubMed ID: 19561527
[TBL] [Abstract][Full Text] [Related]
29. Risk factors and prevention of cardiotoxicity induced by 5-fluorouracil or capecitabine.
Jensen SA; Sørensen JB
Cancer Chemother Pharmacol; 2006 Oct; 58(4):487-93. PubMed ID: 16418875
[TBL] [Abstract][Full Text] [Related]
30. Capecitabine induced vasospastic angina.
Coughlin S; Das S; Lee J; Cooper J
Int J Cardiol; 2008 Oct; 130(1):e34-6. PubMed ID: 17897740
[TBL] [Abstract][Full Text] [Related]
31. Capecitabine-induced coronary vasospasm--a case report.
Rizvi AA; Schauer P; Owlia D; Kallal JE
Angiology; 2004; 55(1):93-7. PubMed ID: 14759096
[TBL] [Abstract][Full Text] [Related]
32. Cardiotoxicity of 5-fluorouracil and capecitabine in Chinese patients: a prospective study.
Peng J; Dong C; Wang C; Li W; Yu H; Zhang M; Zhao Q; Zhu B; Zhang J; Li W; Wang F; Wu Q; Zhou W; Yuan Y; Qiu M; Chen G
Cancer Commun (Lond); 2018 May; 38(1):22. PubMed ID: 29764506
[TBL] [Abstract][Full Text] [Related]
33. Cardiotoxicity following different doses and schedules of 5-fluorouracil administration for malignancy -- a survey of 427 patients.
Tsavaris N; Kosmas C; Vadiaka M; Efremidis M; Zinelis A; Beldecos D; Sakelariou D; Koufos C; Stamatelos G
Med Sci Monit; 2002 Jun; 8(6):PI51-7. PubMed ID: 12070449
[TBL] [Abstract][Full Text] [Related]
34. Alternative treatment options in colorectal cancer patients with 5-fluorouracil- or capecitabine-induced cardiotoxicity.
Deboever G; Hiltrop N; Cool M; Lambrecht G
Clin Colorectal Cancer; 2013 Mar; 12(1):8-14. PubMed ID: 23102544
[TBL] [Abstract][Full Text] [Related]
35. Coronary vasospasm with myocardial stunning in a patient with colon cancer receiving adjuvant chemotherapy with FOLFOX regimen.
Cerny J; Hassan A; Smith C; Piperdi B
Clin Colorectal Cancer; 2009 Jan; 8(1):55-8. PubMed ID: 19203898
[TBL] [Abstract][Full Text] [Related]
36. Capecitabine: a review.
Walko CM; Lindley C
Clin Ther; 2005 Jan; 27(1):23-44. PubMed ID: 15763604
[TBL] [Abstract][Full Text] [Related]
37. Management of patients with persistent chest pain and ST-segment elevation during 5-fluorouracil treatment: report about two cases.
Mafrici A; Alberti A; Corrada E; Ferrari S; Marenna B
Ital Heart J; 2003 Dec; 4(12):895-9. PubMed ID: 14976858
[TBL] [Abstract][Full Text] [Related]
38. Treatment of advanced colorectal cancer in a patient with cardiotoxic reactions to 5-fluorouracil and capecitabine using suboptimal doses.
Cioffi JH; Estes DJ; Florou V; Ardalan B
BMJ Case Rep; 2017 Nov; 2017():. PubMed ID: 29183892
[TBL] [Abstract][Full Text] [Related]
39. Incidence and risk factors for capecitabine-induced symptomatic cardiotoxicity: a retrospective study of 452 consecutive patients with metastatic breast cancer.
Polk A; Shahmarvand N; Vistisen K; Vaage-Nilsen M; Larsen FO; Schou M; Nielsen DL
BMJ Open; 2016 Oct; 6(10):e012798. PubMed ID: 27798021
[TBL] [Abstract][Full Text] [Related]
40. [Angina pectoris and ST-elevation after chemotherapy with 5-fluorouracil].
Spencker S; Schmittel A; Westermann D; Marek A; Schultheiss HP; Witzenbichler B
Internist (Berl); 2007 Jan; 48(1):69-72, 74. PubMed ID: 17177034
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
